The NGS cancer‐hotspot analysis on tumor DNA revealed a c.1632C>A, p.(Asn544Lys) pathogenic variant of the FGFR1 gene (NM_001174063.2) with a VAF of 36%, confirmed by Sanger sequencing. This evidence concerns the gene FGFR1 and cancer.